Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Clinical trial NCT00635596 · COMPLETED
Trial details
- NCT number
- NCT00635596
- Sponsor
- Amgen Research (Munich) GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2014-01-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.